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Abstract
Background: Virtual-reality based rehabilitation (VR) shows potential as an engaging and effective way to improve
upper-limb function and cognitive abilities following a stroke. However, an updated synthesis of the literature is
needed to capture growth in recent research and address gaps in our understanding of factors that may optimize
training parameters and treatment effects.
Methods: Published randomized controlled trials comparing VR to conventional therapy were retrieved from seven
electronic databases. Treatment effects (Hedge’s g) were estimated using a random effects model, with motor and
functional outcomes between different protocols compared at the Body Structure/Function, Activity, and Participation
levels of the International Classification of Functioning.
Results: Thirty-three studies were identified, including 971 participants (492 VR participants). VR produced small to
medium overall effects (g = 0.46; 95% CI: 0.33–0.59, p < 0.01), above and beyond conventional therapies. Small to
medium effects were observed on Body Structure/Function (g = 0.41; 95% CI: 0.28–0.55; p < 0.01) and Activity
outcomes (g = 0.47; 95% CI: 0.34–0.60, p < 0.01), while Participation outcomes failed to reach significance (g = 0.38;
95% CI: -0.29-1.04, p = 0.27). Superior benefits for Body Structure/Function (g = 0.56) and Activity outcomes (g = 0.62)
were observed when examining outcomes only from purpose-designed VR systems. Preliminary results (k = 4)
suggested small to medium effects for cognitive outcomes (g = 0.41; 95% CI: 0.28–0.55; p < 0.01). Moderator analysis
found no advantage for higher doses of VR, massed practice training schedules, or greater time since injury.
Conclusion: VR can effect significant gains on Body Structure/Function and Activity level outcomes, including improvements
in cognitive function, for individuals who have sustained a stroke. The evidence supports the use of VR as an adjunct for
stroke rehabilitation, with effectiveness evident for a variety of platforms, training parameters, and stages of recovery.
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Background
Stroke is one of the leading global causes of disability
[1, 2], with over 17 million individuals worldwide
sustaining a stroke each year [2]. Although stroke
mortality is decreasing with improvements in medical
technology [3], the neurological trauma resulting from
stroke can be devastating, and the majority of stroke
survivors have substantial motor [4, 5], cognitive [6–9]
and functional rehabilitation needs [3, 10, 11], and much
reduced quality of life [3, 12, 13]. Targeted rehabilitation
can help address some of these post-stroke deficits, how-
ever, historically, many individuals, in particular patients
with cognitive impairment, have difficulty engaging in
standard therapies [14–16] at a level that will produce
meaningful and lasting improvements [16–19]. Enriched
and interactive rehabilitation programs are clearly needed
to minimize functional disability [13, 20], increase partici-
pation in age-appropriate roles and activities [21], lead to
greater motivation and treatment compliance [17, 22], and
reduce the long-term expense of care in stroke survivors
[20, 23, 24].
Virtual reality
Virtual reality refers to simulated interactions with
environments and events that are presented to the
performer with the aid of technology. These so-called
virtual environments may mirror aspects of the real
world or represent spaces that are far removed from
it, while allowing various forms of user interaction
through movement and/or speech [25]. Virtual reality
based rehabilitation, or Virtual Rehabilitation (VR),
shows considerable promise as a safe, engaging, inter-
active, patient-centered and relatively inexpensive
medium for rehabilitation training [26–31]. VR has
the potential to target a wide range of motor, func-
tional, and cognitive issues [23], affords methods that
automatically record and track patient performance
[32], and offers a high level of flexibility and control
over therapeutic tasks [17, 18, 33]. This scalability al-
lows patients to train at the highest intensity that
would be possible for their individual ability [34],
while keeping the experience of interaction with thera-
peutic tasks enjoyable and compelling [17, 29]. At the
same time, VR may enable patients with a neurodisability
(like stroke) to practice without excessive physical fatigue
[32, 35] which otherwise may deter continued effort and
engagement in therapy [36, 37].
Currently, there are two main types of VR: purpose-
designed Virtual Environments (VE) and Commercial
Gaming (CG) systems. Both types of systems can pro-
vide augmented feedback, additional forms of sensory
feedback about the patient’s movement over and above
the feedback that is provided as a natural consequence
of the movement itself [11, 38]. VE systems are often
designed by rehabilitation scientists (and others) to en-
hance the delivery of augmented feedback in order to
develop the patient’s sense of position in space [39–41],
to reinforce different movement parameters (like trajec-
tory and endpoint) and reduce extraneous movements
(e.g. excessive trunk displacement) [42, 43].
VE systems are also more likely to involve specially
designed tangible user interfaces used in mixed reality
rehabilitation systems [13] or training of daily functional
activities [44]. By comparison, CG rehabilitation systems
are typically “off-the-shelf” devices such as Wii
(Nintendo), Xbox (Microsoft) and PlayStation (Sony),
which have the advantage of being readily available and
relatively inexpensive when compared with VE systems
[11]. On the other hand, CG systems are typically de-
signed for able-bodied participants and may not consider
the physiological, motor, and cognitive aspects of reco-
very in rehabilitation, and may lack the scalability of
purpose-designed VE systems [45].
Systematic reviews comparing VE and CG systems
There is conflicting evidence about the relative effective-
ness of VE- and CG-based VR systems. In a recent
Cochrane review of VR following stroke [46], VE systems
demonstrated a significant treatment effect on upper-limb
function when compared to controls (d = 0.42; 95%CI:
0.07–0.76), while the effect for CG systems failed to reach
significance (d = 0.50; 95%CI: -0.04-1.04); a caveat, how-
ever, was that only two of nine studies (22%) in these com-
parisons were CG-based. In contrast, a meta-analysis by
Lohse and colleagues of VR following stroke [11] found
no significant difference between VE (g = 0.43, based on
13 studies) and CG interventions (g = 0.76, based on three
studies) on Body Structure/Function level outcomes. For
Activity level outcomes, CG interventions showed a large
but non-significant effect (g = 0.76, p = 0.14), but was
based on only four of 26 studies (15%); VE interventions,
however, showed a significant treatment effect (g = 0.54, p
< .001). Taken together, these two reviews suggest benefits
of VE systems, while previous analyses of CG treatment
effects have been underpowered and inconclusive.
Cognition and VR
Cognitive impairments, including difficulties in atten-
tion, language, visuospatial skills, memory, and execu-
tive function are common and persistent sequelae of
stroke [14, 47] and exert considerable influence on re-
habilitation outcomes [48]. Cognitive dysfunction may
reduce the ability to (re-)acquire motor [25, 49–52] and
functional skills [47], and decrease engagement and
participation in rehabilitation program [48, 53]. While
the important role of cognition in both conventional
and VR-based rehabilitation is increasingly recognized
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[52–54] the impact of VR on cognitive function has not
yet been formally evaluated in a quantitative review.
Analysis of individual domains of functioning
The World Health Organization’s International Classifi-
cation of Functioning, Disability, and Health (ICF-WHO
[55]) is currently one of the most widely used classifica-
tion systems. It is a foundation for understanding
outcome effects in clinical practice [56] and the
preferred means for translating clinical findings in a
patient-centered manner [56]. Under the ICF-WHO,
disability and functioning are seen to arise by the inter-
action of the health condition, the environment, and
personal factors, and can be measured at three main
levels: (i) Body Structure/Function, (ii) Activity (or skill),
and (iii) Participation. The ICF-WHO has been used to
classify outcome measures in studies of VR (for example
[57]) and in recent systematic reviews [11, 58, 59]. A
brief critique of these reviews reveals a number of
important conclusions, but also some significant gaps in
the research.
An early systematic review by Crosbie and colleagues
[60] examined the efficacy of VR for stroke upon motor
and cognitive outcomes. Of the 11 studies reviewed (up
to 2005), only five addressed upper-limb function and
two addressed cognitive outcomes. Overall, the review
reported significant benefits of VR, but only three
studies were RCTs and no effect size estimates were re-
ported. At around the same time, a systematic review by
Henderson and colleagues [61] showed that there was
very good evidence that immersive VR was more benefi-
cial than no therapy for upper-limb rehabilitation in
adult stroke, but insufficient evidence for non-immersive
VR. Comparisons with traditional physical therapy were
less impressive, however.
A 2016 systematic review by Vinas-Diz and colleagues
[62] included both controlled clinical trials and
randomized controlled trials (RCTs) in stroke, and
spanned 2009–2014. The review included 25 papers: four
systematic reviews [19, 46, 63, 64] and 21 original trials.
Evidence for treatment efficacy on upper-limb function
was strong on a mix of measures like the Fugl-Meyer Test,
Wolf Motor Function Test, and Motricity Index. However,
a quantitative analysis of the effects was not undertaken,
and important aspects of treatment implementation like
dose and session scheduling were not formally examined.
A recent systematic review by Santos-Palma and
colleagues [58] examined the efficacy of VR on motor
outcomes for stroke using the ICF-WHO framework,
covering work published up to June 2015. Of the studies
deemed high quality, 20 examined outcomes at the Body
Structure/Function level, 17 at the Activity level, and
eight examined Participation. Intriguingly, positive out-
comes were evident only at the Body Structure/Function
level, while results for Activity and Participation were
not conclusive. Unfortunately, only three studies
addressed manual ability at the Activity level, which
severely limited any evaluation of skill-specific effects.
In a combined systematic review and meta-analysis of
37 RCTs published between 2004 and 2013, Laver and
colleagues [46] present a more comprehensive examin-
ation of the effects of VR on upper-limb function. As
well, they classified outcomes broadly into upper-limb
function, Activities of Daily Living (ADLs) and other as-
pects of motor function. In general, study quality was
low, and the risk of bias high, in roughly one-half of the
studies. Outcomes were significant for upper-limb func-
tion (d = 0.28) and ADLs (d = 0.43), but somewhat
smaller than those reported by Lohse and colleagues
[11]. Results for other aspects of motor function, includ-
ing several at what may be considered the Body Struc-
ture/Function level, were non-significant. Dose varied
considerably between studies, ranging from less than 5 h
to more than 21 h in total. In general, studies that used
higher doses (> 15 h of therapy) were reported as more
effective. Unfortunately, results could not be pooled for
cognitive outcomes, and the importance of additional
treatment implementation parameters like training
frequency and duration, and the impact of specific study
design factors including the recovery stage of partici-
pants and type of control group (i.e. active vs passive)
were not determined.
An updated systematic review by Laver and colleagues
[65], included an additional 35 studies that reported out-
comes for upper limb function and activity. A subset of
only 22 studies that compared VR with conventional
therapy showed no significant effect of VR on upper-
limb function (d = 0.07). As well, there was no significant
difference between higher (> 15 h of therapy), and lower
levels of dose. However, when VR was used in addition
to usual care (10 studies; 210 participants), there was a
significant effect on upper-limb outcomes (d = 0.49). As
before, no significant difference was shown between high
and low dose studies. Unfortunately, analysis of cognitive
outcomes, and moderator analyses including study qual-
ity, and implementation parameters (e.g., daily intensity,
weekly intensity, treatment frequency, and total number
of sessions) were not included in the updated review. As
well, the assessment of study quality was limited to the
5-item GRADE system, the ICF classification system was
not given full consideration, and no distinction was
drawn between treatment as usual (TAU) and active
control groups (TAU + some form of additional
therapy).
Taken together, recent reviews on the use of VR for
adult stroke show encouraging evidence of efficacy at
the level of Body Structure/Function, but mixed results
for Activity and ADLs, and a paucity of evidence bearing
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on Participation. The impact and effectiveness of VR on
cognitive outcomes also remains poorly understood,
despite the important role of cognitive dysfunction in
learning and rehabilitation [17, 18], and increased evi-
dence of interconnection between cognitive function
and motor deficits at the Body Structure/Function,
Activity and Participation levels of the ICF [52]. VE-
based platforms have been suggested to be superior to
CG approaches [46] in promoting motor function, but
until recently there have been few CG studies available
for analysis. As well, other design factors that may mod-
erate treatment effects (like stage of recovery, control
group type) have either not been explored or are too few
in number to draw firm conclusions. There has been
considerable variation in the total dose of VR therapy
[46, 60], and no analysis has yet tested the dose-
response relationship in moderator analyses. Finally, the
bulk of conclusions have relied on qualitative synthesis,
and there is a paucity of quantitative analysis of
empirical data to inform opinion.
In view of limitations in past reviews and continued
acceleration in VR the aim of our review was to conduct
a systematic literature review and meta-analysis to re-
evaluate the strength of evidence bearing on VR of
upper-limb function and cognition in stroke. This review
is critical given evidence that stroke rehabilitation needs
to better optimize intervention techniques during the re-
covery windows that exist in the acute phase [66] and
beyond. Focusing only on RCTs, we consider outcomes
across levels of the ICF-WHO, and analyze the modera-
ting effect of design factors and dose-related parameters.
Methods
The current review was conducted and reported in
accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) state-
ment [67], it should be noted that the protocol was not
registered.
Data sources and search strategy
Scopus, Cochrane Database, CINAHL, The Allied and
Complementary Medicine Database, Web of Science,
MEDLINE, Pre-Medline, PsycEXTRA, and PsycINFO
databases were systematically searched from inception
until 28 June 2017. Boolean search terms included the
following: “stroke, cerebrovascular disease, or cerebrovas-
cular attack” and “Virtual reality, Augment* reality,
virtual gam*” (see Appendix for an example of the full
MEDLINE search strategy).
Inclusion and exclusion criteria
RCT studies published in English in peer-reviewed
journals, utilizing a VR intervention to address either
motor (upper-limb), cognitive, or activities of daily living
in stroke patients were included in the current review
(see Fig. 1). VR was defined as a type of user-computer
interface that involves real-time simulation of an acti-
vity/environment, enabling the user to interact with the
Fig. 1 Population, Intervention, Comparison, Outcome (PICO) Question and the main variables included in the systematic literature review
and meta-analysis
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environment using motor actions and sensory systems.
Comparison groups included “usual care”, “standard
care” or “conventional therapy”, involving physical ther-
apy and/or occupational therapy. Studies were excluded
that applied a “hybrid” approach combining virtual real-
ity with exogenous stimulation or robotics, targeted
lower limb function, recruited a mixed study cohort in-
cluding non-stroke participants, or did not utilize motor,
cognitive, or participation outcome measures.
Identification of relevant studies and data extraction
The eligibility assessment was performed indepen-
dently using a standardized protocol by two of the
authors (AA and JR). After deleting duplicate papers,
the title and abstract of all articles were screened by
the authors to assess suitability for inclusion. Those
considered potentially eligible were read in full. In
addition, reference lists of relevant reviews were
searched by hand. The last hand search was per-
formed 28 June 2017. For articles meeting inclusion
criteria, data on study design, participant characteris-
tics, and intervention outcomes were extracted by
two of the authors (AA and JR). Disagreements
between reviewers were resolved by consensus.
Extracted VR outcomes were organized according to
the three levels of functioning classified by the ICF-
WHO [55] including: (i) Body Structure/Function, which
refers to physiological functions of body systems (e.g.
Fugl Meyer Assessment); (ii) Activity, which refers to the
execution of tasks or actions (e.g. Box and Blocks Test);
and (iii), Participation, which refers to involvement in
life situations (e.g. Motor Activity Log [57]).
Quality assessment
Two authors (AA and PW) assessed the risk of bias of
each included article using the Physiotherapy Evidence
Database (PEDro) Scale [68]. The PEDro Scale rates
methodological quality across 11 bias reducing items re-
lating to the domains of Selection, Performance, Detec-
tion, Information, and Attribution biases [69]. Studies
with PEDro total scores from 6 to 10 were considered
high quality [70]; scores below 6 were considered fair
quality. Disagreements between reviewers were resolved
by consensus.
Quantitative analysis
From the published manuscript, post-intervention
means and standard deviations on each outcome
measure, p values, and sample sizes for the experi-
mental and control groups were entered into Com-
prehensive Meta-Analysis (CMA; Biostat, Englewood,
NJ, USA) version 3.3.070. A random-effects model
was used to compute the effect size estimate, Hedge’s
g, a variation of Cohen’s d that corrects for small
sample sizes. The magnitude of Hedge’s g was catego-
rized as follows: small (≥0.2), medium (≥0.5) and
large (≥0.8) [71]. Pooled effect sizes were calculated
by aggregating the mean effect sizes weighted by each
study’s sample size, and the 95% confidence intervals
(CI) and z scores based on the overall mean and
standard error. Meta-analysis was only performed in
cases where there was more than one study in each
group [72]. Effect size outcomes favoring VR were
assigned a positive value while effects favoring the
control condition (i.e. treatment-as-usual) had a nega-
tive value. Heterogeneity was formally assessed with
the I2 statistic, where an I2 value greater than 50%
indicated significant heterogeneity [71]. The risk of
publication bias was assessed using the Classic fail-
safe N and Egger’s regression test (2-tailed p value).
Finally, moderator analyses were conducted using the
Q statistic to estimate the likelihood of a given
variable moderating observed effect sizes. A total of
ten moderator variables were examined, including five
design factors, and five implementation parameters
(See Table 1).
Results
Following removal of duplicates, 17,300 records were
screened for eligibility. Following the selection process
depicted in Fig. 2, a final sample of 31 articles was iden-
tified for inclusion in this review. Twenty-eight studies
[13, 21, 44, 57, 73–96] utilized an upper-limb training
intervention approach, one also aimed to improve cogni-
tive function [97], and two studies [53, 54] targeted cog-
nitive function alone. The pool of studies included work
conducted in the UK, Korea, Spain, USA, Brazil, Israel,
Sweden, Australia, and New Zealand (see Table 2). Of
the 31 articles, two presented two separate studies for
analysis [21, 91], providing a total of 33 independent
studies. All studies used an RCT design, comparing 492
participants receiving VR (per study M = 14.9, SD = 10.9)
with 479 participants receiving Conventional Therapy
(CT; per study M = 14.5, SD = 11.4).
Participant characteristics
Sample sizes ranged from 4 to 62 participants per group.
Eight studies had less than 10 participants in the VR
group [21, 57, 76, 79, 81, 83, 84, 90], while only five
studies had over 20 participants (range, 20–59) in the
VR group [74, 77–79, 86] (see Table 2). The average age
was 60.0 years (SD = 6.3 years, range 48.2–74.1). The
average time post-stroke for each study (based on 29 in-
dependent studies, four studies [54, 90, 91, 97] did not
report time post-stroke) varied considerably from
1.9 weeks to 427.8 weeks (M = 79.6 weeks, SD = 105.2).
This included seven studies [21, 44, 53, 74, 76, 86, 91]
(21%) conducted during the sub-acute (≤ three months)
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stage (range 1.9–10.3 weeks, M = 3.86 weeks, SD = 3.23),
while the remainder completed VR interventions during
the chronic (> 3 months post-stroke) stage (range 17.2–
427.8 weeks, M = 127.40 weeks, SD = 132.5). Seventeen
studies [13, 21, 53, 57, 74, 77, 79–82, 85, 87, 91, 92, 94]
included both ischemic and hemorrhagic stroke patients,
three included only ischemic stroke patients [78, 86, 93],
and 11 did not report specific details about stroke type.
Only three studies [21, 74] reported data on stroke se-
verity, two utilizing the National Institutes of Health
Stroke Scale (NIHSS) and one study [86] used the
Canadian Neurological Scale of Stroke Severity.
VR and control interventions
Of the 33 independent studies, 19 used a VE ap-
proach and 14 studies evaluated a CG-based therapy
(see Table 3). VE interventions involved either video
capture or tabletop systems. The former required the
patient to be seated in front of a wall display while
grasping a sensor, such as the Reinforced Feedback in
Virtual Environment system [77–79] and the Rehab
Master game-based VE system [75, 76]. Tabletop sys-
tems involved multitouch display technologies (e.g.
[92, 94]), requiring finger touch response [94] or the
manipulation of tangible user interfaces. CG therapies
included Wii (Nintendo [73, 74, 80, 83, 86, 91]),
Xavix [83], EyeToy (PlayStation [88]), IREX system
[53, 82, 97], Xbox Kinect [81, 89], or a combination
of systems [95]. All but two intervention programs
(93%) took place in a hospital, one [90] was home-
based and another provided rehabilitation at a local
community center [92]. Only one study [85] reported
on the number of repetitions per session.
All VR and CT group participants received CT. In
most of the included studies, this “treatment as usual”
was only described in limited terms, but typically
involved aspects of either physio- or occupational
therapy (see Table 3). In 21 studies, CT group partici-
pants also received additional rehabilitation interven-
tions, to match the additional time in therapy
provided to participants randomized to VR. These so-
called “active” control group interventions included,
for example, additional physio- and occupational
therapy [83], or additional standard therapy tailored
Table 1 Moderators included in the analyses
Moderator Type Definition
Design factors
Intervention Type Virtual Environment (VE) design or Computerized Gaming (CG) system
Simulation Type Intervention targeting hand/finger function or interventions targeting overall upper-limb function
Study Quality Moderate Quality (PEDro score≤ 6) or High Quality (PEDro score > 6)
Recovery Stage Sub-Acute (≤3 months post-stroke) or Chronic (> 3 months post-stroke)
Control Group Type Passive (treatment as usual) or Active (treatment as usual + additional rehabilitation) comparison control group
Implementation Parameters
Duration Total number of sessions per intervention (low: < 15 sessions; high: ≥ 15 sessions)
Frequency Number of sessions per week (low: ≤ 3 sessions; high: > 3 sessions)
Dose Total number of minutes per intervention (low: < 400 min; medium: 400–800 min; high: > 800 min)
Daily Intensity Minutes per session (low: ≤ 30 min; high: > 30 min)
Weekly Intensity Total minutes of virtual rehabilitation per week (low: ≤ 100 min; high: > 100 min)
Fig. 2 Four-phase Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) flow diagram, showing the process for
identifying and screening of the articles for inclusion and exclusion
in the systematic literature review and meta-analysis
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Table 3 Description of the virtual rehabilitation interventions, conventional control group therapies, and additional control
treatments, when applicable
First
Author,
Year
Virtual Rehabilitation Intervention Control Group Intervention
Assis, 2014 VE: NeuroR augmented reality system, with virtual shoulder
exercises to extend the upper-limb + TAU
TAU: Standard Therapy (NR)
Ancillary: Relaxation session instructed by physiotherapist followed
by shoulder movement using both unaffected and injured arms
assisted by the physiotherapist and also without the physiotherapist
assistance.
Broeren,
2008
VE: Semi-immersive table-top workbench with haptic device
and 3D computer games + TAU
TAU: Usual activities at the centre, which included different social
activities, creative crafts and physical activities.
Ancillary: NA
Chen, 2015 Study 1 – VE: Wii Nintendo games bowling and boxing games
+ TAUStudy 2 – VE: XaviX games bowling and ladder climbing
games + TAU
TAU: At least one hour of physio- and occupational therapy per
week.
Ancillary: Two traditional devices, the Curamotion exerciser and
the climbing board and bar
Choi, 2014 CG: Wii Nintendo games: swordplay, table tennis, and canoe
+ TAU
TAU: Standard Therapy (NR)
Ancillary: OT that involved goal-oriented and highly repetitive
trainings for that involved composed of stretching and
strengthening exercises using full range of motion of the upper
extremity, which was a task-oriented therapy for the ADL, fine
motor training, and sensory motor recover
Crosbie,
2012
VE: 3D environment system, that included a desktop computer,
a head-mounted display unit, a motion tracking system and
sensors with tasks focused on reaching and grasping. + TAU
TAU: Standard physiotherapy
Ancillary: Delivered by a physiotherapist, experienced in stroke
rehabilitation, and followed a programme of techniques, which
included muscle facilitation, stretching exercises, strengthening
activities and the inclusion of the more affected upper limb in
functional tasks
da Silva Cameirão,
2011
Study 1 - VE: Rehabilitation Gaming System that captures upper
limb movements through color detection; two data gloves to
capture finger flexure creating a virtual environment where an
avatar mimics the movements of the user. Tasks aimed to target
speed, range of motion, grasp and release + TAU for 5 weeks.
Study 2 - VE: Rehabilitation Gaming System that captures upper
limb movements through color detection; two data gloves to
capture finger flexure creating a virtual environment where an
avatar mimics the movements of the user. Tasks aimed to target
speed, range of motion, grasp and release + TAU for 12 weeks.
TAU: Two weekly physiotherapy sessions
Ancillary: involved release or non-specific interactive Wii Nintendo
games either intense occupational therapy targeting object
displacement, grasp and.
da Silva
Ribeiro,
2015
CG: Wii Nintendo games: tennis, hula-hoop, soccer and boxing. +
TAU
TAU: NR
Ancillary: Conventional physiotherapy that included 10-mintes of
upper and lower limb stretching or muscles and trunk, passive,
active-assisted, and active-resisted mobilisation of the trunk (10 min),
straightening and balance reactions with rapid shifts (10 min),
scapular mobilisation (5 min), active or active-assisted upper-limb
diagonal movements (15 min) and grasping activities (10 min)
Duff, 2010 VE: Adaptive mixed reality rehabilitation system + TAU TAU: Standard Therapy (NR)
Ancillary: UL therapy: pegboard reaching tasks, bead threading
reaching tasks, cone reaching tasks, and ROM and coordination
exercises
Gamito,
2015
VE: Cognitive stimulation with Serious Games mobile technology,
that included several daily live activities e.g. buying items,
findings way to the minimarket, finding a virtual character. + TAU
TAU: Standard Therapy (NR)
Ancillary: NA
Givon 2015 CG: Microsoft Xbox Kinect, Sony PlayStation 2 Eyetoy, Sony
PlayStation 3 MOVE, Nintendo Wii Fit and the SeeMe VR
systems. + TAU
TAU: Standard Therapy (NR)
Ancillary: Participants were then divided into pairs or triads to
perform functional activities such as picking up and transferring
objects from one side of the room to the other.
Gyuchang,
2013
CG: Xbox Kinect + TAU TAU: Standard occupational therapy
Ancillary: NA
Housman,
2009
Therapy Wilmington Robotic Exoskeleton (T-WREX) a passive
(non-robotic) arm that provides support for the arm against
gravity and measures arm movement and traces hand grasp as
users interact with computer games
TAU: Standard Therapy (NR)
Ancillary: Conventional semiautonomous training
In, 2012 VE: Virtual Reality Reflection Therapy program + TAU TAU: Standard Therapy (NR)Ancillary: The control group received
the same treatment as intervention group, but the monitor was off.
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Table 3 Description of the virtual rehabilitation interventions, conventional control group therapies, and additional control
treatments, when applicable (Continued)
First
Author,
Year
Virtual Rehabilitation Intervention Control Group Intervention
Kihoon,
2012
CG: Interactive Rehabilitation and Exercise System (IREX) + TAU TAU: Standard Therapy (NR)
Ancillary: NA
Kim, 2011 CG: Interactive Rehabilitation and Exercise System (IREX) + TAU TAU: Computer assisted cognitive rehabilitation
Ancillary: NA
Kim, 2012 CG: Nintendo Wii Tennis and boxing games TAU: Previous therapy (not specified), no therapy at the time of
intervention
Ancillary: NA
Kiper, 2011 VE: Reinforced feedback in virtual environment (RFVE) system
+ TAU
TAU: Standard Therapy (NR)
Ancillary: Additional Standard Therapy (tailored to individual needs)
Kiper, 2014 VE: Reinforced feedback in virtual environment (RFVE) system
+ TAU
TAU: Standard Therapy (NR)
Ancillary: Additional Standard Therapy (tailored to individual needs)
Kong, 2016 CG: Nintendo Wii Tennis, golf, baseball, table tennis, basketball,
cycling, sword play, airplane flight control and boxing games
(Wii Sports and Wii Sports resort packages) + TAU
TAU: Standard Therapy consisted of physical and occupational
therapy one hour a day, Monday to Friday.
Ancillary: NA
Kottink,
2014
VE: The Furball Hunt table-top rehabilitation game + TAU Standard therapy tailored to individual needs
Ancillary: Exercises required reaching for targets, such as objects
positioned on a table top, or using specific, non-(electro)
mechanical equipment (bow, pegs in holes, placing disks, etc.)
Kwon, 2012 CG: Interactive Rehabilitation and Exercise System (IREX) + TAU TAU: Standard physical and occupational therapy
Ancillary: NA
Lee, 2013 CG: Xbox Kinect + TAU TAU: Standard occupational therapy
Ancillary: NA
Levin, 2012 VE: Virtual games and a virtual supermarket (e.g., Birds & Balls,
Soccer, Volleyball, VMall) + TAU
TAU: NR
Ancillary: Occupational therapy, including exercises involving
reaching for and holding cones, cups, and other objects in all
motion planes with and without external loading
Piron, 2009 VE: Therapist telerehabilitation equipment (VRRS.net®),
participant can observe his/her movement on the screen
(augmented feedback), and observe the correct trajectory
pre-recorded in the virtual scene (virtual teacher) + TAU
TAU: NR
Ancillary: Conventional physical therapy, with patients performing
specific exercises (e.g. touching different targets arranged in a
horizontal plane in front of them) with a strategy of progressive
complexity.
Piron, 2010 VE: Reinforced feedback in a virtual environment (RFVE)
system + TAU
TAU: Conventional physical therapy
Ancillary: The CT program was based on Bobath principles. The
patients performed specific exercises with the upper limb with
progressive complexity. First, the patients were asked to control
isolated motions without postural control; subsequently, postural
control was included; and finally, complex motion with postural
control was practiced.
Saposnik,
2016
CG: Nintendo Wii, Wii sports and Game Party 3 packages
+ TAU
TAU: Standard Therapy (NR)
Ancillary: Recreational computer-generated activities
(passive control)
Shin, 2014 VE: The RehabMaster game-based system + TAU TAU: Standard Therapy (NR)
Ancillary: Occupational therapy
Shin, 2015 VE: The RehabMaster game-based system + TAU TAU: Standard Therapy (NR)
Ancillary: Occupational therapy
Sin, 2013 CG: Xbox Kinect Microsoft + TAU TAU: Standard Therapy (NR)
Ancillary: NA
Standen,
2017
VE: Home-based VR system with three games (Spacerace,
Spongeball, Balloonpop)
TAU: Previous therapy, no therapy at the time of intervention
Ancillary: NA
Yavuzer,
2008
CG: Playstation EyeToy games (Kung-foo, goal attack,
MrChef, Dig and HomeRun) + TAU
TAU: Physiotherapy, occupational therapy, speech therapy
(if needed)
Ancillary: “Sham therapy” (not specified, passive control)
Yin, 2014 VE: VE of a local supermarket setting + TAU TAU: Standard Therapy (NR)
Ancillary: NA
Note: CG Commercial Gaming, NA Not Applicable, NR Not Reported, TAU Treatment as Usual, VE Virtual Environment
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to individual needs [77, 79, 93] (see Table 3). In con-
trast, 12 studies utilized “passive” control groups that
received no additional intervention beyond treatment
as usual.
Dose and session scheduling
For all VR approaches combined, the mean overall Dose
was 685 min (SD = 355, range 200–1440 min), with a
mean Daily Intensity of 42 min (SD = 15, median 30,
range 20–60 min) and Weekly Intensity of 153.9 min
(SD = 80.38, median = 135, range 60–800). The mean
Frequency was three sessions a week (range one-five ses-
sions), and the median Duration was 18 sessions (range,
4–36 sessions).
ICF-WHO outcomes
Twenty-seven studies reported Body Structure/Function
level outcomes, with the Fugl-Meyer Assessment-Upper
Extremity (FMA-UE) as the most common instrument
(21 studies). An additional study [95] utilized the FMA-
UE to classify baseline participant characteristics but did
not include it as an outcome measure. Twenty-nine
studies reported Activity level outcomes, most com-
monly using the Box and Blocks Test (seven studies),
Functional Independent Measure (eight studies), and
Barthel Index (six studies). Participation level outcomes
were reported by five studies, most often utilizing the
Motor Activity Log instrument (four studies). Only four
studies [53, 54, 91, 97] reported data on cognitive out-
comes (see Table 4), each of these studies reported data
on multiple cognitive outcomes, and all of these were
included in the analyses (Table 5).
Risk of bias
The methodological quality of included studies was
generally high (see Table 4), with an average PEDro total
score of 7.06 (SD = 1.26, range 5–9). Eligibility criteria
were specified in all studies, and all but one study [83]
specified random allocation of participants. However,
despite more rigorously focusing only on RCT designs,
However, despite more rigorously focusing only on RCT
designs, four [21, 80, 85, 92] of the included studies were
rated only fair quality, due to the omission of concealed
allocation, blinding, and intention to treat analyses. In
addition, the Egger’s intercept value for all outcomes
combined was 1.23, p = 0.02 (two-tailed), suggesting
pronounced asymmetry and an increased likelihood that
smaller studied tended to report larger than average ef-
fects [98]. To minimize the risk of publication bias all
reported effect size outcomes were based on a random-
effects model to give more weight to larger trials [99].
Main effects of VR after stroke
For all outcomes combined (see Fig. 3 and
Additional file 1: Figure S1), the average effect size
for VR interventions was small to medium (g = 0.46;
95% CI: 0.33–0.59, p < 0.01), with significant benefit
of VR compared to CT. The overall fail-safe N was
high at 439, and heterogeneity minimal (I2 = 0%), sug-
gesting a robust finding. Both VE and CG approaches
were significantly more effective than CT, with an
average small effect size for CG (g = 0.33; 95% CI:
0.14–0.51, p < 0.01), and an average medium effect
size for VE interventions (g = 0.58; 95% CI: 0.41–0.76,
p < 0.01). Moderator analysis confirmed the difference
between VE and CG-based approaches was statisti-
cally significant [Q(1) = 3.96, p = 0.047].
The average effect size for cognitive outcomes was
small but significant (g = 0.45, 95% CI: 0.02–0.88, p
= 0.04). Heterogeneity between studies was minimal
(I2 = 14.69%), but the fail-safe N was only 2, suggest-
ing a tenuous finding. For upper-limb motor and
functional outcomes, data was examined at each of
the three ICF-WHO levels (see Fig. 3 and
Additional file 2: Figure S2). Small overall to
medium effects were observed on Body Structures/
Function (g = 0.41; 95% CI: 0.28–0.55; p < 0.01) and
Activity outcomes (g = 0.47; 95% CI: 0.34–0.60, p <
0.01), while Participation outcomes were non signifi-
cant (g = 0.38; 95% CI: -0.29-1.04, p = 0.27).
Moderator analysis
Moderator analysis (see Fig. 4) found no significant
difference in the overall outcomes of interventions that
utilized an active or passive control group [Q(1) = 0.05,
p = 0.83], and between moderate and high quality studies
[Q(1) = 0.001, p = 0.98], and between studies with low
and high sample size [Q(1) = 0.67, p = 0.41]. Moreover,
there was no significant difference in overall outcomes
for patients receiving VR during either the sub-acute or
chronic stage [Q(1) = 2.39, p = 0.12], and between inter-
ventions that focused specifically on hand function or
overall upper-limb function [Q(1) = 2.82, p = 0.09].
Different levels of dose (high, medium, low) had no
significant effect on the overall effect [Q(2) = 2.22, p =
0.33]. Variations in daily intensity [Q(1) = 0.16, p = 0.70],
frequency [Q(1) = 0.67, p = 0.71], weekly intensity [Q(1)
= 0.03, p = 0.85] and duration [Q(1) = 2.77, p = 0.10] also
had no significant impact.
Meaningful comparisons could not be performed be-
tween different levels of severity (determined using gold
standard FMA-UE outcome measure); there was only a
single study that used a group of mild severity [82]. The
larger (moderate-severe) group clustered tightly around
a mean severity of 34.9 (SD: 8.9). When the mild severity
study [82] was pulled-out from the overall analysis, the
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Table 4 Outcome measures included in the data analysis
Body Structure and Function Activity Participation Cognitive
First
Author,
Year
FMA-
UE
MAS Other outcomes BBT ARAT FIM BI Other outcomes
Assis, 2014 ✓
Broeren,
2008
✓
Chen,
2015
✓ ✓ ✓
Choi, 2014 ✓ MFT; Grip Strength ✓ ✓ A-CPT Correct Detection, Reaction
Time, Commission Error; V-CPT
Correct Detection, Reaction Time
Crosbie,
2012
✓ MI
da Silva
Cameirão,
2011
✓ FMA arm; FMA hand/
wrist
✓ CAHAI; MI
da Silva
Ribeiro,
2015
✓ FMA Overall, Physical
Functioning (overall
motor functioning
SF-36 Social Aspects,
Vitality
Duff, 2010 ✓ FMA range of
motion, pain,
sensation
SIS; WMFT total;
WMFT time.
MAL Amount of
Use, Quality of
Movement
Gamito,
2015
TP; WMS III
Givon
2015
Grip Strength
Weaker Hand; Gait
Speed (Motor Overall)
✓
Housman,
2009
✓ Grip strength Racho level (UL);
Racho Speed (UL)
MAL Amount of
Use, Quality of
Movement
In, 2012 ✓ ✓ MFT ✓ JHFT
Kihoon,
2012
WMFT total, hand,
arm
MVPT Reaction time in seconds;
MVPT score; Visual discrimination;
Visual memory; visual closure
Kim, 2011 ✓ MI VCPT; ACPT;
WCW; CCW;
FDST; BDST; FVST; BVST;
ViLT; VeLT; TMT-A; TOL
Kim, 2012 ✓ PASS Motor overall ✓
Kiper, 2011 ✓ ✓ ✓
Kiper, 2014 ✓ Mean Duration of
Movement – time;
peak; speed
✓
Kong,
2016
✓ ✓ ✓
Kottink,
2014
✓ ✓
Kwon,
2012
✓ MFT; FMA arm,
hand, wrist
✓ K-MBI Self Care
Lee, 2013 ✓ MMT Muscle
Strength;
✓
Levin,
2012
✓ RPSS ✓ WMFT MAL Amount of
Use, Quality of
Movement
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overall effect for all outcomes combined remained small
(g = 0.47; 95% CI: 0.34–0.60, p < 0.01), with significant
benefit of VR compared with CT.
On the basis of the statistically significant advantage
for VE approaches relative to CG designs, treatment
effects for VE-based rehabilitation alone were also
analyzed at each ICF-WHO level (see Fig. 5). There
was a medium effect overall on Body Structure/Func-
tion (g = 0.54; 95% CI: 0.35–0.73; p < 0.01), and a
medium to large effect on Activity (g = 0.62; 95% CI:
0.43–0.81, p < 0.01). The overall effect on Participa-
tion was unchanged as no CG approaches examined
outcomes in this ICF-WHO domain. Within-group
heterogeneity was minimal for Activity (I2 = 0%) and
Body Function (I2 = 0%) outcomes, and large for
Participation outcomes (I2 = 65%).
Follow-up data
Twelve studies also included follow-up data: six studies re-
assessed outcomes four to six weeks after intervention [44,
76, 79, 86, 94, 96] and six studies re-assessed outcomes
eight to 26 weeks later [74, 87, 88, 90, 93, 95]. Both CG [74,
86, 88, 95] and VE [44, 76, 79, 87, 90, 93, 94, 96] ap-
proaches, and sub-acute [44, 74, 76, 86] and chronic [79,
87, 88, 90, 93–96] populations were represented (see Fig. 6).
There was no significant difference in treatment effect
[Q(2) =0.35, p = 0.72] between the four to six week
follow-up (g = 0.36, p = 0.02), the eight to 26 week fol-
low-up (g = 0.58, p < 0.01), and the overall effect of VR ob-
served immediately following intervention (g = 0.46, p <
0.01). Differences between CG and VE approaches were not
statistically significant at either follow-up [4–6 weeks: Q(1)
= 2.03, p = 0.15; 8–26 weeks: Q(1) = 0.10, p = 0.76]. Overall,
small to medium effects for both Body Structure/Function
and Activity level outcomes were observed at both the four
to six week and the eight to 26 week follow-ups. Only three
studies examined Participation outcomes at a follow-up
[44, 87, 90], which were small, and non-significant (p =
0.48), in keeping with the pre-post findings. No studies ex-
amined cognitive outcomes at follow-up. Consistent with
the pre-post data analysis, treatment effects did not vary as
a function of the implementation parameters (i.e. dose, daily
intensity, weekly intensity, frequency, duration), or recovery
stage (i.e. sub-acute vs. chronic).
Table 4 Outcome measures included in the data analysis (Continued)
Body Structure and Function Activity Participation Cognitive
First
Author,
Year
FMA-
UE
MAS Other outcomes BBT ARAT FIM BI Other outcomes
Piron,
2009
✓ ✓
Piron,
2010
✓ ✓
Saposnik,
2016
✓ ✓ ✓ WMFT
Shin, 2014 ✓ ✓
Shin, 2015 ✓ SF-36 Role limitation
due to physical
problems; SF-36
Vitality
Sin, 2013 ✓ ✓
Standen,
2017
NHPT NEADL; WMFT MAL Amount of
Use, Quality of
Movement;
MAL-activities
Yavuzer,
2008
Brunnstorm stages
hand, Upper
Extremity; FIM Self
Care
Yin, 2014 ✓ ✓ ✓ MAL Amount of
Use, Quality of
Movement
Note: ACPT Auditory continuous performance test, AF Augmented Feedback, ARAT Action Research Arm Test, AS Ashworth scale, BDST Backward digit span test,
BVST Backward visual span test, BI Barthel Index, BBT Box and Blocks test, CCW Color of word in word-color test, CAHAI Chedoke Arm and Hand Activity Inventory,
CSI Composite Spasticity Index, FMA Fugl-Meyer Assessment, FMA-UE Fugl-Meyer Assessment-Upper Extremity FDST: Forward digit span test, FVST Forward visual
span test, JHFT Jebsen Hand Function Test, K-MBI Korean version of the Modified Barthel Index, MAS: Modified Ashworth Scale, MAL Motor Activity Log, MFT
Manual Function Test, MI Motricity Index, TPT Toulouse–Pieron Test, VCPT Visual continuous performance test, ViLT Visual learning test, VeLT Verbal learning test,
TMT-A Trail Making Test-A, TOL Tower of London test, QOM Quality of Movement, RPSS Reaching Performance Scale for Stroke, WMFT Wolf Motor Function Test,
WMS-III Wechsler Memory Scale Third Edition, WCW Word in word-color test
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Discussion
VR is an engaging form of therapy for stroke [19]
and suggested to enhance motor, functional, and
cognitive performance [11, 19, 46, 54], whether
delivered via VE [11, 46] or CG [11]. While recent
reviews of VR therapy have shown improvement in
upper limb function, superior to conventional
physical therapy [11, 19, 46, 58, 62], we know little
of treatment effects across all ICF-WHO levels and
how outcomes vary along different implementation
parameters and design factors [19, 46], resulting in
uncertainties about the optimal training protocol
that affords the greatest efficacy. The aim of this
study was to address these gaps in understanding by
Table 5 PEDro Scale risk of bias ratings for the included studies
First Author, Year C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 TOTAL
Assis, 2014 1 1 0 0 0 0 0 1 1 1 1 6
Broeren, 2008 1 1 0 1 0 0 0 1 0 0 1 5
Chen, 2015 1 0 0 1 0 0 1 1 1 1 1 7
Choi, 2014 1 1 1 1 0 0 1 1 1 1 1 9
Crosbie, 2012 1 1 1 1 0 0 1 1 1 1 1 9
da Silva Cameirão, 2011 1 1 0 0 0 0 1 0 0 1 1 5
da Silva Ribeiro, 2015 1 1 1 1 0 0 1 1 0 1 1 8
Duff, 2010 1 1 0 1 0 0 1 0 0 1 1 6
Gamito, 2015 1 1 0 0 0 0 0 1 1 1 1 6
Givon, 2015 1 1 0 1 0 0 1 1 1 1 1 8
Housman, 2009 1 1 1 1 0 0 1 1 0 1 1 8
In, 2012 1 1 0 1 0 0 0 0 0 1 1 5
Kihoon, 2012 1 1 0 1 0 0 0 1 0 1 1 6
Kim, 2011 1 1 0 1 0 0 0 1 1 1 1 7
Kim, 2012 1 1 0 1 0 0 0 0 0 1 1 5
Kiper, 2011 1 1 0 1 0 0 0 1 1 1 1 7
Kiper, 2014 1 1 0 1 0 0 0 1 1 1 1 7
Kong, 2016 1 1 1 1 0 0 1 1 1 1 1 9
Kottink, 2014 1 1 0 1 0 0 1 1 0 1 1 7
Kwon, 2012 1 1 0 1 1 0 1 1 1 1 1 9
Lee, 2013 1 1 0 0 0 0 0 1 1 1 1 6
Levin, 2012 1 1 0 1 0 0 1 1 0 1 1 7
Piron, 2009 1 1 1 0 0 0 1 1 1 1 1 8
Piron, 2010 1 1 1 0 0 0 1 1 1 1 1 8
Saposnik, 2016 1 1 0 1 0 0 1 1 1 1 1 8
Shin, 2014 1 1 0 1 0 0 1 1 0 1 1 7
Shin, 2015 1 1 0 1 0 0 1 1 0 1 1 7
Sin, 2013 1 1 0 1 0 0 1 1 0 1 1 7
Standen, 2017 1 1 1 1 0 0 0 1 0 1 1 7
Yavuzer, 2008 1 1 1 1 0 0 1 1 1 1 1 9
Yin 2014 1 1 1 1 0 0 0 0 0 1 1 6
Note: “1” indicates a study met the criteria, “0” indicates there was not enough information to make an assessment or the criterion was not met.
C1 = Eligibility criteria were specified. C2 = Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order
in which treatments were received). C3 = Allocation was concealed. C4 = The groups were similar at baseline regarding the most important prognostic
indicators. C5 = There was blinding of all subjects. C6 = There was blinding of all therapists who administered the study. C7 = There was blinding of all
assessors who measured at least one key outcome. C8 = Measures of at least one key outcome were obtained from more than 85% of the subjects
initially allocated to groups. C9 = All subjects for whom outcome measures were available received the treatment or control condition as allocated or,
where this was not the case, data for at least one key outcome was analyzed by “intention to treat.” C10 = The results of between-group statistical
comparisons are reported for at least one key outcome. C11 = The study provides both point measures and measures of variability for at least one
key outcome
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Fig. 3 Forest plot showing the main effect-sizes of Virtual Rehabilitation after stroke on the motor, functional, and cognitive outcomes combined;
the three levels of the International Classification of Functioning (Body Function outcomes included Fugl-Meyer Assessment-Upper Extremity and
Modified Ashworth Scale; Activity outcomes included Box and Blocks Test; Participation outcomes included Motor Activity Log and Quality of
Movement); and cognitive outcomes using the random-effects model. Notes: CG: Computerized Gaming; CI: Confidence Intervals; CT:
Conventional Treatment; ICF: International Classifacation of Functioning; VE: Virtual Environment; VR: Virtual Rehabilitation
Fig. 4 Forest plot showing the main moderator analyses of Virtual Rehabilitation outcomes after stroke using the random-effects model. Note:
AR: Additional Rehabilitation; CI: Confidence Intervals; CT: Conventional Treatment; TAU; Treatment As Usual; VR: Virtual Rehabilitation
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analyzing the current evidence base on VR of upper-
limb and cognitive function in stroke, in a combined
systematic review and meta-analysis.
Overall, the current review of 33 RCTs found that
when compared with conventional therapies, VR
interventions produced a small to medium overall
effect (g = 0.46), above and beyond conventional
physical rehabilitation. Specifically, small to medium
effects were observed on Body Structure/Function (g
= 0.41) and Activity outcomes (g = 0.47), while Par-
ticipation outcomes (g = 0.38) were highly variable
(I2 = 65%) but overall non-significant (p = 0.26). A
small to medium effect on cognitive outcomes was
shown (g = 0.41), albeit based on only four studies.
Intriguingly, the effect of VR was not moderated by
dose-related parameters, and no moderator effects
for chronicity were evident. These results are dis-
cussed in detail below.
Overall effectiveness of virtual rehabilitation
The extent of motor recovery after conventional
stroke rehabilitation is often “modest” [100, 101] with
no significant advantage between different approaches
[100, 102]. When compared with these conventional
interventions (including occupational therapy and
physiotherapy), the current meta-analysis showed an
additional small to medium treatment effect in favor
of VR, above and beyond the gains of treatment as
usual. The magnitude of this benefit was comparable
to that shown in earlier quantitative reviews [11, 19,
46, 65] and reflects an important advance in rehabili-
tation outcomes. Other attempts to identify novel
Fig. 5 Forest plot showing the main effect-sizes of Virtual Environment therapy after stroke on the three levels of the International Classification
of Functioning using the random-effects model. Body Function outcomes included Fugl-Meyer Assessment-Upper Extremity and Modified
Ashworth Scale; Activity outcomes included Box and Blocks Test; Participation outcomes included Motor Activity Log and Quality of Movement.
Note: CI; Confidence Intervals; CT: Conventional Treatment; ICF: International Classifacation of Functioning; VE: Virtual Environment
Fig. 6 Forest plot showing the follow-up effects of Virtual Rehabilitation after stroke on the motor, functional, and cognitive outcomes combined
using the random-effects model Note: CI; Confidence Intervals; ICF: International Classifacation of Functioning
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adjunctive therapies to boost the effects of conven-
tional rehabilitation have been less successful. For ex-
ample, a review of robotic-assisted therapy for stroke
patients with upper-limb impairment [103] showed no
significant difference between intensive conventional
therapy and robotic-assisted therapy groups in terms
of motor recovery, activities of daily living, strength,
and motor control.
Virtual environment versus commercial gaming systems
The current review evaluated two main types of VR
interventions: purpose-designed VE platforms were
examined in 19 studies and commercially available
CG systems in 14. Previous reviews have also
examined the separate impact of these two types of
intervention, but with too few CG studies to make
any firm conclusions about relative efficacy [11, 46].
In contrast to the previous two major reviews, which
included only 17% [11] and 22% [46] CG-based stu-
dies, almost half (42%) of the studies included in the
current review were CG-based interventions, suggest-
ing a growing interest in off-the-shelf solutions.
In the current review, both VE and CG intervention
types were significantly superior to conventional
therapies, with medium effect sizes observed for VE
platforms (g = 0.59) and small effects for CG systems
(g = 0.33). This difference between VR approaches was
statistically significant, and suggests that while both
VE and CG systems afford good training effects over-
all, VE-based systems are somewhat superior [46].
This finding supports the value of customizing
rehabilitation tasks according to the clinical needs
and capacities of patients. Consistent with previous
reviews [11, 46] the positive effect of VE approaches
was observed mainly on outcomes at the Body
Structure/Function and Activity levels of the ICF,
which is discussed in the next section.
Virtual rehabilitation outcomes by domains of function
Over 50 different outcome measures were used by
studies included in the current review, underlining
the importance of standardized classification using the
ICF-WHO [58, 104]. For outcomes at the Body
Structure/Function and Activity levels, effects sizes for
VR (VE and CG combined) were significant (0.41 and
0.47, respectively). Effects at these levels of the ICF-
WHO were more pronounced, however, when VE
systems were considered separately: 0.54 and 0.62 for
Body Structure/Function and Activity, respectively,
compared with 0.27 and 0.32 for CG systems. The
results for VE approaches were comparable to
previously reported effect sizes at the Body Function
(g = 0.48), and Activity (g = 0.54) levels [11], which
had been based on outcomes from both upper and
lower limb interventions combined.
The current meta-analysis of RCTs (published up
to June 2017) showed strong evidence of meaningful
change across the Body Structure/Function and Ac-
tivity levels of the ICF-WHO, unlike earlier reviews
[46, 58]. First, we showed significant effects at the
Body Structure/Function level, where the earlier re-
view of Laver and colleagues showed no change on a
group of “other outcomes” that were largely at this
ICF-WHO level. Second, our review showed that the
largest effect sizes were consistently identified at the
Activity level whereas Palma and colleagues [58]
found inconclusive support and Laver et al. [46] re-
ported relatively small effects on upper-limb function
(d = 0.28). Finally, treatment effects at the Participa-
tion level were small (g = 0.38) and non-significant.
Variation in the magnitude of effect across studies in
our review (g ranging from − 0.37 to 2.04 over five
studies) may reflect issues in the assessment of par-
ticipation outcomes, which is currently an imprecise
science [105].
Cognitive outcomes
While cognitive impairment is common post-stroke
[16, 20, 27], and cognitive and motor systems over-
lap at a structural and functional level [9, 20], only
four [53, 54, 91, 97] studies included in the current
meta-analysis measured cognitive outcomes. While
preliminary, the overall effect of VR on cognition
was encouraging, with a mean effect size of g = 0.45.
The limited number of studies did not permit any
conclusions about the superiority of either VE or CG
approaches. Palma and colleagues [58] also reviewed
cognitive outcomes (from four RCTs), but found no
advantage for a VR approach. However, the relevance
of several included studies was questionable. One
study compared VR with a computerized cognitive
rehabilitation program, not with physical therapy
[106], a second study contained no identifiable cog-
nitive outcome measures [107] and in a third study,
the mental function under investigation was mood
state, rather than cognitive status [75]. The fourth
study was also included in the current meta-analysis
[91]. The results of the current review appear more
valid, and provide encouragement that VR can con-
tribute to cognitive rehabilitation. Moving forward,
researchers and clinicians are encouraged to be
mindful of the inter-relationship between motor and
cognitive systems [9] and the potential cognitive
benefits of motor-based stroke rehabilitation using
VR [25, 31, 54]. For example, a within-group study
by Kizony et al. [51] found preliminary evidence
supporting the interaction between motor and
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cognitive function in stroke patients undergoing VR.
A more recent study by Subramanian and colleagues
[50] provided further evidence of the association be-
tween cognitive and motor recovery. Moreover, it
was shown that patient’s psychological well-being
can also affect motor learning using VR [50], and
should also be taken into account in future studies
of VR in stroke.
Implementation parameters and design factors
Dose-effect relationships remain inconclusive in the VR
area, and in need of further investigation. Reviewing
the literature published between 1999 and 2004,
Crosbie and colleagues [60] found VR was most
commonly delivered three times per week for 1–
1.5 h, over a 2–4 week period (i.e. 6–18 h total).
Similarly, in their review of the literature from 2008
to 2015, Palma et al. [58] reported the average dose
of VR was 17.6 h for upper limb motor function re-
habilitation, and 13.2 h for motor activity rehabilita-
tion. These trends were continued in the current
review, with the average VR intervention comprised
of 40 min sessions delivered three days per week for
6 weeks, for a total of approximately 12 h. However,
there was large variability in these implementation
parameters, with protocols providing up to 60 min
sessions, up to five times per week, for as many as
36 sessions. While a higher number of repetitions
and longer training times are argued to be more
beneficial for motor learning [108], VR outcomes are
argued not to be exclusively dependent on dose [46].
In the current review, moderator analysis also found
no clear added benefit of higher doses or massed
practice of VR, suggesting a ceiling after which gains
plateau. While the dose of rehabilitation may not be
the most important factor affecting recovery [109],
the average intensity, frequency and duration of VR
training identified in the current review appeared to
provide an effective schedule for cognitive and motor
function outcomes, while reducing the chance of
participant fatigue or burn out that may occur under
higher intensity training.
Active versus passive control groups
There was no difference in effect sizes (g = 0.45 c.f. 0.48)
for interventions that utilized an active control
group (i.e. additional conventional therapy beyond
just treatment as usual) or a passive one (i.e. treat-
ment as usual only). This was an unexpected finding
as active control group designs are preferred for
their capability to presumably control for Hawthorne
effects and other biases when comparison groups are
not balanced in terms of time in therapy. However,
the current findings suggest that the use of a passive
control group does not inflate the effect size for the
intervention group. It also suggests that those treat-
ment strategies embedded in active conditions may
not add substantially to the training effects usually
observed for treatment as usual. This finding pro-
vides credence to studies that lack the resourcing to
implement an active control group design and just
proceed with a treatment as usual group, which is
the case more often than not in rehabilitation
research [110].
Sub-acute versus chronic stage
Moderator analysis showed that VR administered in
the sub-acute (g = 0.25) and the chronic stages (g =
0.51) were both effective. However, only seven
studies included in the current review intervened
early after stroke, and the optimal time window for
delivering VR remains an issue for further study. For
the chronic group, there was a large variation in the
time since stroke (range 6 months to several years).
While it may be argued that participants with
longer-term impairment remained responsive to VR
treatment, early intervention is still recommended
[111, 112] to address neurological changes before
chronic disability ensues [101]. As particular treat-
ment modalities are refined with advances in the
technology (e.g., delivery of augmented feedback)
there will be unique opportunities to enhance neuro-
plastic changes during this critical time period [113].
Outcomes at follow-up
A third of all studies included follow-up assessment
[44, 74, 76, 79, 86–88, 90, 93–96]. Participant reten-
tion was generally high, with only one study experi-
encing attrition rates over 10% at follow-up [86].
Follow-up duration was four weeks in five studies
[44, 76, 79, 86, 94], six weeks in one study [96],
eight weeks in two studies [90, 93], 13 weeks in
three studies [74, 88, 95] and 26 weeks in one study
[87]. Over all follow-up durations, the initial gains
reported immediately following VR training were
preserved. These findings are encouraging, and sug-
gest that a discrete period of VR can affect longer-
lasting improvements in overall motor function, and
on ICF-WHO Body Structure/Function and Activity
level outcomes in particular. By comparison, there is
accumulating evidence that early improvements after
conventional rehabilitation may not be sustained
long-term after stroke [114, 115]. Notably, the
current review showed that gains were maintained
regardless of VR approach (CG or VE), dosing (i.e.
frequency, intensity, or duration of training), or stage
of recovery (i.e. sub-acute or chronic). Surprisingly,
no studies examined cognitive outcomes at follow-
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up, and the durability of post-training improvements
in this domain remains unknown. The stability of
gains over periods longer than six months has also
not been explored but should be encouraged in fu-
ture research. Also for further study are questions
about whether booster sessions or other strategies
such as activity monitoring, goal setting, or feedback
systems [116] are needed to optimize stroke survi-
vors’ longer-term outcomes after VR.
Risk of bias
To maximize the quality of evidence in this review,
all of the included studies were Level 1b (RCTs) to
Level 2b (small RCTs) according to the Centre for
Evidence-Based Medicine [117]. As evaluated for-
mally using the PEDro Scale, the quality of studies
was also generally high. Not surprisingly, the only
design component consistently omitted was the
blinding of participants, which is difficult to achieve
using novel and distinct interventions like VR [46].
One study described their methodology as a double-
blind procedure [82], but while participants may
have been naïve to the intended outcomes of the
study it is unlikely they were unaware of their group
assignment (VR vs. passive control group). The
current study did not include a search and review of
unpublished (grey) literature, which could be impor-
tant to account for publication bias (or file drawer
effect) [118]. The current review specifically focused
on published, peer-review articles to ensure the high
quality of included data, but performed a fail-safe N
[119] calculation to account for missing studies and
grey literature. Fail-safe N value of 439: that is, 13
missing studies for every observed study would be
required for the overall effect of VR to be nullified,
further supporting the observed efficacy of VR. With
the risk of biases minimized, we are confident that
VR, and in particular VE, can be recommended as a
useful adjunct or alternative to conventional therapy
when retraining motor and cognitive function follo-
wing stroke. The ability of VR to enhance experience-
dependent neuroplasticity is suggested but demands
new research to investigate changes at the brain level.
These recommendations are discussed below.
Limitations and directions for future research
The current review did not extend to a formal in-
vestigation of active ingredients (i.e. those aspects of
VR that are having the most profound impact on
functioning), which remains an important and unre-
solved issue in VR. What makes this issue particu-
larly hard to dissect is the sheer variety in types of
interface, augmented feedback, setting, and so on
across different studies. It is likely there are both
generic and more specific effects of VR on neuro-
plastic changes and the process of skill learning it-
self. For example, novelty and engagement are
critical to any rehabilitation paradigm and can be
captured by a number of well-designed (game-like)
VE platforms, or popular CG systems like Wii,
Kinect, and PlayStation [90]. The capability of VR to
scale levels of difficulty and to provide appropriate
rewards to users in the context of gameplay and ad-
vancement between levels is critical to CG. Use of
augmented feedback (known to be important in
motor learning) is one factor that will vary greatly
with interface design and the type of human-
computer interaction that a given system affords
[36]. Componential approaches to system evaluation
will be particularly valuable in future research, vary-
ing a critical ingredient that is thought to predict an
outcome while holding all other factors constant.
The effect of different neurological characteristics
on VR rehabilitation outcomes is also in need of
examination. Most studies in the current review used
mixed samples of hemorrhagic and ischemic clients;
only three studies sampled exclusively ischemic
stroke patients [78, 86, 93]. Some studies suggest
that hemorrhagic stroke may result in more severe
cognitive, motor and functional impairment than is-
chemic stroke [120, 121]. By comparison, other work
shows that differences between stroke types are mar-
ginal across these domains [122–124]. Future investi-
gations would benefit from comparison of these
stroke types to test the impact of mixed cohorts.
Moreover, consistent reporting of details including
lesion location (e.g. Oxfordshire Community Stroke
Project Classification) and hemisphere, and initial se-
verity and symptom profiles (e.g. National Institutes
of Health Stroke Scale; modified Rankin Scale), will
assist in identifying the neurological characteristics
of stroke more or less responsive to VR.
Many studies in the current review had small
participant numbers. With only an average of 15
participants per group, a number of studies lacked
sufficient statistical power to examine more than one
or two outcomes [125], and were likely underpow-
ered to examine interactions, predictors, or multi-
variate effects. As we recommend examining
outcomes across all three levels of the ICF-WHO,
including cognitive outcomes, larger-n studies are
recommended in the future, with power calculations
pointing to in excess of 20 participants per treat-
ment arm.
Variation in the choice of primary outcome measure
also limits comparison between studies. The VR re-
search field should consider developing a consensus
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statement on evaluation research to aid the
consistency in measurement. For example, at the Body
Structure/Function level, the FMA might be consid-
ered as a “gold standard” in the absence of a better
tool at this point in time. At the Activity level, the
Box and Blocks Test has been shown to correlate
very highly with longer test batteries that assess skill
(like the Action Research Arm Test), and could be in-
cluded as a standard, easy to administer measure.
Due to a limited number of studies reporting cognitive
outcomes, the current review could only report on cogni-
tion as a unified concept, rather than its more specific
domains. Taken together, there is a need to include well-
validated assessment of cognition.
The far transfer of training effects to important as-
pects of daily functioning, independence, and quality
of life was examined in only five of the current
studies, all of which utilized a VE approach [13, 44,
57, 87, 90]. The overall effect size on Participation
outcomes was non-significant (p = 0.26). This result
mirrored an earlier review by Saposnik and Levin [19]
which identified only one study reporting on (social)
participation. By comparison, the review of Lohse and
colleagues [11] identified a single study that reported
a significant effect on participation outcomes. How-
ever, Lohse and colleagues [11] misclassified the Jeb-
sen Taylor Hand Function Test as a Participation
measure when in fact it is usually classified as an Ac-
tivity level outcome [59, 126]. In our review we ob-
served high variability in results, ranging from non-
significance (g = − 0.37) to a large significant effect (g
= 2.04). The latter study was the only home-based
intervention and involved a control group that com-
pleted their conventional rehabilitation before the
study started. One or both of these unique features
may explain the size of the observed effect. Overall,
efficacy of VR at the Participation level of the ICF-
WHO remains inconclusive (see also [58]) and the
amount of evidence bearing on it is very limited [19,
58]. We recommend examination of far-transfer Par-
ticipation outcomes as standard practice.
Implications for practice
Knowledge of the pattern of treatment effects across
ICF levels has important implications for the design
of tailored interventions for stroke and evidence-
based recommendations for care. Stronger effects for
VE-based systems over CG suggest that the added ex-
pense of acquiring purpose-designed systems might be
a good investment for clinicians, backed, of course,
by well-controlled evaluation studies. However, at this
point, we still do not have sufficient data to make
strong predictions about the (far-transfer) effects of
such training on Participation. In cases where cost
and access to VE systems is an issue, CG systems will
still leverage outcomes at the Body Structure/Function
and Activity levels.
There is too little data to yet make firm conclu-
sions about the impact of VR on cognition. However,
there are a number of examples where cognitive per-
formance has been enhanced through what are es-
sentially motor-based interventions for the upper
limbs. For example, for patients with traumatic brain
injury (TBI), Mumford and colleagues [38] showed
VR produces a significant subjective improvement in
attention and memory function.
Taken together, clinicians and researchers alike are
encouraged to seek out purpose-designed VE systems
that can boast high-quality evidence for their efficacy.
The principled and evidence-based approach to the
design, implementation, and evaluation of VE instru-
ments confers a considerable therapeutic advantage at
the level of functional movement skill. As a matter of
course, future research needs to extend the evaluation
of outcomes across all ICF-WHO levels.
As mentioned, the moderator analysis was unable to
detect a linear dose-response relationship, as no
advantage for higher dosing on any of the VR
approaches or rehabilitation outcomes were found.
Future studies should seek to explore the more active
ingredients of VR, to maximize both the efficacy and
the efficiency of treatment rather than simply relying
on higher doses. Implications for patient engagement,
retention, and satisfaction remain to be explored.
Conclusion
The physical and cognitive impairment resulting from
stroke is persistent and prominent, and the prospect of re-
covery both compelling and elusive. VR interventions offer
the unique opportunity for patients to interact in an
enriched environment, providing structured, scalable train-
ing opportunities augmented by multi-sensory feedback to
enhance skill learning and neuroplasticity through repeated
practice. Findings from this review suggest VR has an
added advantage over conventional interventions, and can
produce immediate and longer-term improvements in
motor function and the performance of cognitive and
motor activities following stroke. The evidence-based effi-
cacy of a VR approach extends to patients in both the acute
and chronic recovery stage, utilizing a spaced training
schedule delivered via either purpose-designed or commer-
cially available systems. Continued application of this prom-
ising technology is encouraged, to refine our understanding
of the factors contributing to the beneficial effects of VR,
and to promote the transfer of gains to participation
outcomes.
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